Bone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma.
Bone-marrow-based gene methylation markers may act as candidate epigenetic biomarkers for risk stratification in DLBCL, but results cannot yet support direct clinical judgement for hematopoietic stem cell transplantation.